MENUNews Archive
Date: 05/15/2012
Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily.
Date: 05/15/2012
The use of single positron emission computed tomography (SPECT)/computed tomography (CT) has been reported to change clinical management in a significant number of thyroid cancer patients, according to research presented in the May issue of The Journal of Nuclear Medicine.
Date: 04/30/2012
G. Lita Smith, M.S., R.N., A.C.N.P., a nurse practitioner in the Breast Care Center and nurse practitioner supervisor at the U-M Rogel Cancer Center, is one of 11 cancer care providers being honored with the 2012 American Cancer Society Lane W. Adams Quality of Life Award.
Date: 04/25/2012
Surgeons are not always including radiation oncologists early enough in a patient's treatment decision-making process, leaving some patients uninformed of all of their treatment options and potentially leading to more mastectomies over breast-conserving therapy.
Date: 04/24/2012
University of Michigan study reveals need for better screening, prevention of venous thromboembolism as outpatient surgery grows.
Date: 04/18/2012
Written by Nicole Fawcett; and Mary Masson: contact via email [email protected] or telephone 734-764-2220.
Date: 04/16/2012
When women at high risk of breast cancer viewed a customized web-based decision guide about prevention options, they were more likely to make a choice about prevention.
Date: 04/11/2012
A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study.
Date: 04/03/2012
Pathology evaluations done on-site cut operating time, reduced cost, study shows. Resulting in fewer women needing repeat breast cancer surgeries." />
Date: 04/02/2012
Arul M. Chinnaiyan, M.D., Ph.D., of the University of Michigan Rogel Cancer Center will lead the Dream Team project titled Precision Therapy for Advanced Prostate Cancer.